KLTOW
Klotho Neurosciences, Inc.
Price Chart
No historical data available
Latest Quote
$0.09
-0.01 (-9.28%)
Current Price
| Previous Close | $0.09 |
| Open | $0.17 |
| Day High | $0.10 |
| Day Low | $0.08 |
| Volume | 18,574 |
Stock Information
| Cash Equivalents | $7.35M |
| Net Income | $-11.29M |
| Exchange | NCM |
Recent Price History
No history data available. Data will be fetched automatically.
About Klotho Neurosciences, Inc.
Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $356,603 | $76,214 | $24,366 | $0 |
| Total Expenses | $5,540,236 | $631,322 | $574,374 | $1,109,069 |
| Other Income Expense | $-253,533 | $78 | $147 | $44 |
| Other Non Operating Income Expenses | $-251,572 | $78 | $147 | $44 |
| Net Non Operating Interest Income Expense | $-356,603 | $-76,214 | $-24,366 | $0 |
| Interest Expense Non Operating | $356,603 | $76,214 | $24,366 | $0 |
| Operating Expense | $5,540,236 | $631,322 | $574,374 | $1,109,069 |
| General And Administrative Expense | $5,540,236 | $631,322 | $574,374 | $1,109,069 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-6,150,372 | $-707,458 | $-598,593 | $-1,109,025 |
| Net Interest Income | $-356,603 | $-76,214 | $-24,366 | $0 |
| Normalized Income | $-6,148,411 | $-707,458 | $-598,593 | $-1,109,025 |
| Net Income From Continuing And Discontinued Operation | $-6,150,372 | $-707,458 | $-598,593 | $-1,109,025 |
| Total Operating Income As Reported | $-5,540,236 | $-631,322 | $-574,374 | $-1,109,069 |
| Net Income Common Stockholders | $-6,150,372 | $-707,458 | $-598,593 | $-1,109,025 |
| Net Income | $-6,150,372 | $-707,458 | $-598,593 | $-1,109,025 |
| Net Income Including Noncontrolling Interests | $-6,150,372 | $-707,458 | $-598,593 | $-1,109,025 |
| Net Income Continuous Operations | $-6,150,372 | $-707,458 | $-598,593 | $-1,109,025 |
| Pretax Income | $-6,150,372 | $-707,458 | $-598,593 | $-1,109,025 |
| Operating Income | $-5,540,236 | $-631,322 | $-574,374 | $-1,109,069 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-5,791,808 | $-631,244 | $-574,227 | $-1,109,025 |
| Total Unusual Items | $-1,961 | - | - | - |
| Total Unusual Items Excluding Goodwill | $-1,961 | - | - | - |
| EBITDA (Bullshit earnings) | $-5,793,769 | $-631,244 | $-574,227 | $-1,109,025 |
| EBIT | $-5,793,769 | $-631,244 | $-574,227 | $-1,109,025 |
| Diluted NI Availto Com Stockholders | $-6,150,372 | $-707,458 | $-598,593 | $-1,109,025 |
| Tax Provision | $0 | $0 | - | - |
| Gain On Sale Of Security | $-1,961 | - | - | - |
| Selling General And Administration | $5,540,236 | $631,322 | $574,374 | $1,109,069 |
| Other Gand A | $2,890,663 | $631,322 | $572,974 | $287,919 |
| Salaries And Wages | $2,649,573 | $0 | $1,400 | $821,150 |
Fetched: 2026-03-12
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-1,114,209 | $-1,614,341 | $-1,030,735 | $289,385 |
| Total Assets | $2,457,365 | $2,192,706 | $2,539,449 | $1,041,503 |
| Total Non Current Assets | $2,299,554 | $2,186,058 | $2,209,910 | $736,983 |
| Goodwill And Other Intangible Assets | $2,299,554 | $2,186,058 | $2,209,910 | $736,983 |
| Other Intangible Assets | $2,299,554 | $2,186,058 | $2,209,910 | $736,983 |
| Current Assets | $157,811 | $6,648 | $329,539 | $304,520 |
| Prepaid Assets | $94,070 | $3,840 | $3,667 | $3,667 |
| Cash Cash Equivalents And Short Term Investments | $63,741 | $2,808 | $75,872 | $300,853 |
| Cash And Cash Equivalents | $63,741 | $2,808 | $75,872 | $300,853 |
| Cash Financial | $63,741 | $2,808 | $75,872 | $300,853 |
| Receivables | - | - | $250,000 | $0 |
| Debt | ||||
| Net Debt | $208,012 | $1,464,462 | $1,271,646 | - |
| Total Debt | $271,753 | $1,467,270 | $1,347,518 | - |
| Current Debt And Capital Lease Obligation | $271,753 | $1,467,270 | $1,347,518 | - |
| Current Debt | $271,753 | $1,467,270 | $1,347,518 | - |
| Other Current Borrowings | - | $135,000 | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,272,020 | $1,620,989 | $1,360,274 | $15,135 |
| Total Non Current Liabilities Net Minority Interest | $24,486 | $0 | $0 | $0 |
| Derivative Product Liabilities | $24,486 | $0 | - | - |
| Current Liabilities | $1,247,534 | $1,620,989 | $1,360,274 | $15,135 |
| Current Notes Payable | $271,753 | $1,332,270 | $1,347,518 | $0 |
| Payables And Accrued Expenses | $975,781 | $153,719 | $12,756 | $15,135 |
| Payables | $63,686 | $151,259 | $8,014 | $15,135 |
| Accounts Payable | $63,686 | $151,259 | $8,014 | $15,135 |
| Equity | ||||
| Common Stock Equity | $1,185,345 | $571,717 | $1,178,670 | $1,025,863 |
| Total Equity Gross Minority Interest | $1,185,345 | $571,717 | $1,179,175 | $1,026,368 |
| Stockholders Equity | $1,185,345 | $571,717 | $1,179,175 | $1,026,368 |
| Retained Earnings | $-10,562,799 | $-3,923,677 | $-3,216,219 | $-2,617,626 |
| Preferred Stock Equity | - | - | $505 | $505 |
| Other | ||||
| Ordinary Shares Number | $27,080,915 | $15,130,393 | $15,130,393 | $15,130,393 |
| Share Issued | $27,080,915 | $15,130,393 | $15,130,393 | $15,130,393 |
| Tangible Book Value | $-1,114,209 | $-1,614,341 | $-1,031,240 | $288,880 |
| Invested Capital | $1,457,098 | $2,038,987 | $2,526,188 | $1,025,863 |
| Working Capital | $-1,089,723 | $-1,614,341 | $-1,030,735 | $289,385 |
| Total Capitalization | $1,185,345 | $571,717 | $1,179,175 | $1,026,368 |
| Additional Paid In Capital | $11,745,436 | $4,493,881 | $3,539,003 | $3,539,003 |
| Capital Stock | $2,708 | $1,513 | $856,391 | $104,991 |
| Common Stock | $2,708 | $1,513 | $855,886 | $104,486 |
| Preferred Stock | $0 | $0 | $505 | $505 |
| Current Accrued Expenses | $912,095 | $2,460 | $4,742 | $0 |
| Duefrom Related Parties Current | - | - | $250,000 | $0 |
Fetched: 2026-03-12
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-3,070,009 | $-460,804 | $-724,981 | $-284,021 |
| Operating Activities | ||||
| Operating Cash Flow | $-2,946,512 | $-446,916 | $-599,573 | $-284,021 |
| Cash Flow From Continuing Operating Activities | $-2,946,512 | $-446,916 | $-599,573 | $-284,021 |
| Operating Gains Losses | $1,961 | - | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-123,497 | $-13,888 | $-125,408 | - |
| Investing Cash Flow | $-123,497 | $23,852 | $-125,408 | $0 |
| Cash Flow From Continuing Investing Activities | $-123,497 | $23,852 | $-125,408 | $0 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-120,000 | $0 | - | - |
| Issuance Of Capital Stock | $295,000 | $0 | $750,000 | $250,000 |
| Financing Cash Flow | $3,130,942 | $350,000 | $500,000 | $250,000 |
| Cash Flow From Continuing Financing Activities | $3,130,942 | $350,000 | $500,000 | $250,000 |
| Net Other Financing Charges | $778,942 | $350,000 | $500,000 | $250,000 |
| Net Common Stock Issuance | $175,000 | $0 | $750,000 | $250,000 |
| Common Stock Issuance | $295,000 | $0 | $750,000 | $250,000 |
| Other | ||||
| Issuance Of Debt | $2,177,000 | $0 | - | - |
| Interest Paid Supplemental Data | $2,460 | $78,496 | $19,624 | $0 |
| Income Tax Paid Supplemental Data | $551,593 | $0 | $0 | $0 |
| End Cash Position | $63,741 | $2,808 | $75,872 | $300,853 |
| Beginning Cash Position | $2,808 | $75,872 | $300,853 | $334,874 |
| Changes In Cash | $60,933 | $-73,064 | $-224,981 | $-34,021 |
| Common Stock Payments | $-120,000 | $0 | - | - |
| Net Issuance Payments Of Debt | $2,177,000 | $0 | - | - |
| Net Short Term Debt Issuance | $2,177,000 | $0 | - | - |
| Short Term Debt Issuance | $2,177,000 | $0 | - | - |
| Net Intangibles Purchase And Sale | $-123,497 | $23,852 | $-125,408 | $0 |
| Sale Of Intangibles | $0 | $37,740 | - | - |
| Purchase Of Intangibles | $-123,497 | $-13,888 | $-125,408 | $0 |
| Change In Working Capital | $150,573 | $260,542 | $-2,380 | $3,854 |
| Change In Other Current Liabilities | $60,022 | $0 | - | - |
| Change In Payables And Accrued Expense | $180,781 | $260,715 | $-2,380 | $2,239 |
| Change In Accrued Expense | $1,064,465 | $-2,282 | $4,742 | $0 |
| Change In Payable | $-883,684 | $262,997 | $-7,122 | $2,239 |
| Change In Account Payable | $-187,573 | $103,997 | $-7,122 | $-12,896 |
| Change In Tax Payable | $-568,111 | $0 | - | - |
| Change In Income Tax Payable | $-568,111 | $0 | - | - |
| Change In Prepaid Assets | $-90,230 | $-173 | $0 | $1,615 |
| Other Non Cash Items | $391,753 | - | - | - |
| Stock Based Compensation | $2,649,573 | $0 | $1,400 | $821,150 |
| Asset Impairment Charge | $10,000 | $0 | - | - |
| Gain Loss On Investment Securities | $1,961 | - | - | - |
| Net Income From Continuing Operations | $-6,150,372 | $-707,458 | $-598,593 | $-1,109,025 |
Fetched: 2026-03-12